Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $17.20.
Several research analysts have recently issued reports on SENS shares. HC Wainwright decreased their price target on Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, May 12th. Stifel Nicolaus reduced their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a report on Monday, May 11th. Weiss Ratings downgraded shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 28th. Finally, Mizuho decreased their target price on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, July 15th.
Read Our Latest Research Report on SENS
Senseonics Holdings, Inc. Common Stock Price Performance
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. The business had revenue of $11.71 million for the quarter. Research analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current year.
Insider Buying and Selling
In other news, Director Douglas A. Roeder bought 22,686 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were purchased at an average price of $5.56 per share, with a total value of $126,134.16. Following the completion of the acquisition, the director directly owned 144,635 shares in the company, valued at approximately $804,170.60. This trade represents a 18.60% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 4.70% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock
Several hedge funds have recently modified their holdings of SENS. Ausdal Financial Partners Inc. boosted its stake in Senseonics Holdings, Inc. Common Stock by 50.0% during the third quarter. Ausdal Financial Partners Inc. now owns 105,000 shares of the company’s stock valued at $46,000 after buying an additional 35,000 shares in the last quarter. GSK plc acquired a new stake in Senseonics Holdings, Inc. Common Stock in the 4th quarter valued at about $60,000. Townsend Asset Management Corp NC ADV bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the 4th quarter valued at about $60,000. Kestra Advisory Services LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the 1st quarter worth approximately $68,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth approximately $71,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
Read More
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
